300026 Stock Overview
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Tianjin Chase Sun Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.86 |
| 52 Week High | CN¥4.87 |
| 52 Week Low | CN¥3.01 |
| Beta | -0.069 |
| 1 Month Change | -1.53% |
| 3 Month Change | 15.22% |
| 1 Year Change | -6.99% |
| 3 Year Change | -40.25% |
| 5 Year Change | 9.97% |
| Change since IPO | 65.14% |
Recent News & Updates
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Seems To Use Debt Quite Sensibly
Nov 22
We Think That There Are More Issues For Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Than Just Sluggish Earnings
Nov 01Recent updates
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Seems To Use Debt Quite Sensibly
Nov 22We Think That There Are More Issues For Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Than Just Sluggish Earnings
Nov 01Investors Appear Satisfied With Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Prospects
Sep 26These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well
Aug 02There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings
Jun 12Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03
May 22This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts
May 21Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 04Shareholder Returns
| 300026 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -7.9% | -3.1% | -2.1% |
| 1Y | -7.0% | -4.4% | 9.8% |
Return vs Industry: 300026 underperformed the CN Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: 300026 underperformed the CN Market which returned 9.8% over the past year.
Price Volatility
| 300026 volatility | |
|---|---|
| 300026 Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 300026 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300026's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 5,910 | Dan Zheng | www.chasesun.cn |
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, medical and healthcare services, and smart supply chain for pharmaceutical and medical devices. It also provides its products in the areas of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases, as well as anti-tumor.
Tianjin Chase Sun Pharmaceutical Co.,Ltd Fundamentals Summary
| 300026 fundamental statistics | |
|---|---|
| Market cap | CN¥11.60b |
| Earnings (TTM) | CN¥165.81m |
| Revenue (TTM) | CN¥5.63b |
69.9x
P/E Ratio2.1x
P/S RatioIs 300026 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300026 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.63b |
| Cost of Revenue | CN¥2.75b |
| Gross Profit | CN¥2.88b |
| Other Expenses | CN¥2.71b |
| Earnings | CN¥165.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.055 |
| Gross Margin | 51.12% |
| Net Profit Margin | 2.95% |
| Debt/Equity Ratio | 9.0% |
How did 300026 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield51%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 21:27 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianjin Chase Sun Pharmaceutical Co.,Ltd is covered by 20 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xin Zhang | AJ Securities Co., Ltd |
| Wen Wen Shen | Avic Securities Co., Ltd |
| Yalei Yan | Bohai Securities Co., Ltd. |